The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of atezolizumab in BCG-unresponsive non-muscle invasive bladder cancer: SWOG S1605 (NCT #02844816).
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Amgen; Asieris Pharmaceuticals; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Biosyent; Bristol-Myers Squibb; EMD Serono; Ferring; H3 Biomedicine; Janssen Oncology; MDxHealth; Merck; Roche Canada; Sanofi; Urogen pharma
Speakers' Bureau - Pfizer; TerSera
Research Funding - GenomeDx; GlaxoSmithKline; iProgen; Sitka
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Sanofi
Other Relationship - Sanofi
 
Catherine Tangen
No Relationships to Disclose
 
Parminder Singh
Consulting or Advisory Role - Bayer; Genentech/Roche; Janssen Oncology; Pfizer; Prometheus
Research Funding - EMD Serono
 
David James McConkey
Honoraria - BioClin Therapeutics; H3 Biomedicine; Janssen Oncology
Research Funding - AstraZeneca; BioClin Therapeutics
Travel, Accommodations, Expenses - BioClin Therapeutics; H3 Biomedicine
 
Scott Lucia
Stock and Other Ownership Interests - 3D Biopsy
 
William Thomas Lowrance
Research Funding - Myriad Genetics (Inst)
 
Vadim S Koshkin
Consulting or Advisory Role - AstraZeneca; Dendreon; Janssen
 
Kelly Lynn Stratton
Honoraria - Bayer; Dendreon (Inst); Oakstone Publishing; Sun Pharma
Consulting or Advisory Role - AMRO Pharma (Inst); Bayer (Inst); Bayer (Inst); Clovis Oncology (Inst); Dendreon (Inst); Large Urology Group Practice Association (Inst); Myriad Genetics (Inst); Sanofi (Inst)
Speakers' Bureau - Bayer
Research Funding - Advantage Pharmaceuticals (Inst); Anchiano (Inst); Astellas Pharma (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); EMD Serono (Inst); Ferring (Inst); Genentech (Inst); Myovant Sciences (Inst); Myriad Genetics (Inst); Myriad Genetics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Dendreon; Dendreon (Inst); Myriad Genetics
 
Trinity Bivalacqua
Honoraria - Photocure
 
Elad Sharon
No Relationships to Disclose
 
Wassim Kassouf
Consulting or Advisory Role - Ferring; Janssen; Merck; Roche; Sesen Bio
Research Funding - Roche (Inst); Sesen Bio (Inst)
 
Sima P. Porten
Honoraria - photocure
Consulting or Advisory Role - Bristol-Myers Squibb; KDx Diagnostics; Photocure
Research Funding - Photocure (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Richard Carlton Bangs
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - American Institutes for Research; Facing our Risk of Cancer Empowered; National Cancer Institute; National Cancer Institute; NCI; Summa Health System; SWOG; SWOG; University of Puerto Rico; University of Puerto Rico
 
Melissa Plets
No Relationships to Disclose
 
Seth P. Lerner
Honoraria - Dava Oncology; MSD; Nucleix
Consulting or Advisory Role - Anchiano; Ferring; Merck Sharp & Dohme; miR Scientific; QED Therapeutics; Roche/Genentech; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; Roche/Genentech; Urogen pharma; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Travel, Accommodations, Expenses - Dava Oncology; Ferring; MSD; Nucleix
 
Ian Murchie Thompson
Consulting or Advisory Role - Magforce; Profound Medical
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme